These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26316320)

  • 1. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.
    Antony-Debré I; Duployez N; Bucci M; Geffroy S; Micol JB; Renneville A; Boissel N; Dhédin N; Réa D; Nelken B; Berthon C; Leblanc T; Mozziconacci MJ; Favier R; Heller PG; Abdel-Wahab O; Raslova H; Latger-Cannard V; Preudhomme C
    Leukemia; 2016 Apr; 30(4):999-1002. PubMed ID: 26316320
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele.
    Sakurai M; Kasahara H; Yoshida K; Yoshimi A; Kunimoto H; Watanabe N; Shiraishi Y; Chiba K; Tanaka H; Harada Y; Harada H; Kawakita T; Kurokawa M; Miyano S; Takahashi S; Ogawa S; Okamoto S; Nakajima H
    Blood Cancer J; 2016 Feb; 6(2):e392. PubMed ID: 26849013
    [No Abstract]   [Full Text] [Related]  

  • 3. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).
    Owen C
    Leuk Res; 2010 Feb; 34(2):141-2. PubMed ID: 19695705
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell acute lymphoblastic leukemia arising from familial platelet disorder.
    Nishimoto N; Imai Y; Ueda K; Nakagawa M; Shinohara A; Ichikawa M; Nannya Y; Kurokawa M
    Int J Hematol; 2010 Jul; 92(1):194-7. PubMed ID: 20549580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysmegakaryopoiesis, a clue for an early diagnosis of familial platelet disorder with propensity to acute myeloid leukemia in case of unexplained inherited thrombocytopenia associated with normal-sized platelets.
    Latger-Cannard V; Philippe C; Jonveaux P; Lecompte T; Favier R
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):e264-6. PubMed ID: 21900832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
    Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
    Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.
    Manchev VT; Bouzid H; Antony-Debré I; Leite B; Meurice G; Droin N; Prebet T; Costello RT; Vainchenker W; Plo I; Diop M; Macintyre E; Asnafi V; Favier R; Baccini V; Raslova H
    J Cell Mol Med; 2017 Jun; 21(6):1237-1242. PubMed ID: 27997762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML).
    Shiba N; Hasegawa D; Park MJ; Murata C; Sato-Otsubo A; Ogawa C; Manabe A; Arakawa H; Ogawa S; Hayashi Y
    Blood; 2012 Mar; 119(11):2612-4. PubMed ID: 22138511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent CDC25C mutations drive malignant transformation in FPD/AML.
    Yoshimi A; Toya T; Kawazu M; Ueno T; Tsukamoto A; Iizuka H; Nakagawa M; Nannya Y; Arai S; Harada H; Usuki K; Hayashi Y; Ito E; Kirito K; Nakajima H; Ichikawa M; Mano H; Kurokawa M
    Nat Commun; 2014 Aug; 5():4770. PubMed ID: 25159113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
    Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
    Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome.
    Jongmans MC; Kuiper RP; Carmichael CL; Wilkins EJ; Dors N; Carmagnac A; Schouten-van Meeteren AY; Li X; Stankovic M; Kamping E; Bengtsson H; Schoenmakers EF; van Kessel AG; Hoogerbrugge PM; Hahn CN; Brons PP; Scott HS; Hoogerbrugge N
    Leukemia; 2010 Jan; 24(1):242-6. PubMed ID: 19946261
    [No Abstract]   [Full Text] [Related]  

  • 12. A
    Wang CP; Ferreira JE; Placek A; Aguayo-Hiraldo P; Raca G; Wood BL; Miller KP; Coates T; Freyer DR; Kovach AE
    Leuk Lymphoma; 2024 Sep; 65(9):1357-1361. PubMed ID: 38733629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
    Owen CJ; Toze CL; Koochin A; Forrest DL; Smith CA; Stevens JM; Jackson SC; Poon MC; Sinclair GD; Leber B; Johnson PR; Macheta A; Yin JA; Barnett MJ; Lister TA; Fitzgibbon J
    Blood; 2008 Dec; 112(12):4639-45. PubMed ID: 18723428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow Morphology Associated With Germline
    Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
    Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
    Schlegelberger B; Heller PG
    Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene of the issue: RUNX1 mutations and inherited bleeding.
    Morgan NV; Daly ME
    Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.
    Balbach ST; Makarova O; Bonn BR; Zimmermann M; Rohde M; Oschlies I; Klapper W; Rössig C; Burkhardt B
    Leukemia; 2016 Apr; 30(4):970-3. PubMed ID: 26216196
    [No Abstract]   [Full Text] [Related]  

  • 19. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
    Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
    [No Abstract]   [Full Text] [Related]  

  • 20. Whole-exome sequencing confirmation of a novel heterozygous mutation in RUNX1 in a pregnant woman with platelet disorder.
    Obata M; Tsutsumi S; Makino S; Takahashi K; Watanabe N; Yoshida T; Tamiya G; Kurachi H
    Platelets; 2015; 26(4):364-9. PubMed ID: 24853048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.